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INTRODUCTION
Several osteoblast culture systems have documented that cells can progress through a developmental sequence of bone cell differentiation from a proliferating cell to a fully mature osteocyte-like cell embedded in a mineralized extracellular matrix [1] . Fetal rat calvarialderived cultures have been shown to form nodules of multilayered cells having a bone-like tissue organization [2, 3] . In concert with the developing hone matrix, three stages of bone cell maturation in vitro are characterized morphologically and by subsets of genes expressed temporally during a proliferation period, during initial formation of the extracellular matrix (maturation period), and in a final stage, during ordered deposition of hydroxyapatite in the extracellular matrix (mineralization period) [4, 5] . During proliferation, genes related to growth control (e.g., histones) and production of an extracellular matrix (e.g., collagen, TGF131, and fibronectin) are expressed at maximal levels. Postproliferatively, other genes become induced to their maximal levels such as alkaline phosphatase and matrix gla protein. With the onset of mineralization, genes such as osteocalcin and osteopontin become induced to 100-fold levels. While alkaline phosphatase activity is expressed in all cells throughout the culture, in situ hybridization methods to characterize expression of these genes at the single cell level revealed that osteocalcin and osteopontin are expressed only in cells associated with the boneforming nodule [3] .
Several studies by light microscopy have documented changes in development of the bone nodule in response to the steroid hormones, vitamin D, and glucocorticoid. For example, 1,25(OH)2D, -treated proliferating cells in culture can result in an inhibition of nodule formation [6, 7] ; in contrast, dexamethasone stimulates nodule production [8, 9] . Furthermore, differences in module- tion of specific genes by a hormone were variable and dependent upon the developmental stage of the osteoblast at the time hormone responsiveness was examined [6, 9, 101 . For example, 1,25(OH)2D3 was reported to inhibit cell proliferation and downregulate collagen mRNA and alkaline phosphatase in proliferating or immediately postproliferative cultures, whereas these parameters were stimulated in mature osteoblasts in mineralized cultures. Osteocalcin and osteopontin were induced by both vitamin D and dexamethasone from 20-to 50-fold immediately in postproliferative cells but were stimulated by these hormones only 2-to 3-fold in mature cultures when basal levels were maximum.
In the present study, we have addressed whether the effects of these steroid hormones are targeted to specific cells at different stages of maturation throughout the developmental sequence of osteoblast differentiation. This can be readily examined at the single cell level in these cultures that develop a bone tissue-like organization. We have examined histone H4, which is coupled to DNA synthesis and thus a marker of cellular proliferation, collagen, osteocalcin, and osteopontin mRNA expression by in situ hybridization in response to 1,25(OH)2D3 and the synthetic glucocorticoid, dexamethasone. We report selective changes in both cell morphology and gene expression in response to these hormones in particular subsets of cells in these osteoblast cultures. Our observations demonstrate that proliferating osteoblasts in vitro, which had expressed genes reflecting the mature phenotype in vivo, can be markedly altered by steroid hormones in their ability to progress through the normal developmental stages of osteoblast differentiation. Postproliferative differentiated osteoblasts associated with the bone nodule respond to vitamin D and glucocorticoid, as reflected by both cell shape changes and changes in the mRNA levels of expressed genes. However, the postproliferative cuboidal internodular cells which were alkaline phosphatase positive, but having no surrounding mineralized bone extracellular matrix, could not be induced by the hormones to express genes represented in mature osteoblasts within the mineralized matrix. These findings establish, at the single cell level, developmental stage-specific responsiveness by the osteoblast to steroid hormones within the context of structural parameters analogous to those in bone tissue.
METHODS AND MATERIALS
Cell culture. Calvaria from fetal rats of 21 days gestation were isolated and subjected to sequential digestions of 20, 40, and 90 min at 37°C in 2 mg/ml collagenase P (Boehringer-Mannheim, Indianapolis, IN) with 0.25% trypsin (Gibco, Grand Island, NY) 5]. The cells of the first two digests were discarded, and those released from the third digestion were plated in minimal essential medium (MEM; Gibco) supplemented with 10% fetal calf serum (FCS), 50 pg/m1 ascorbic acid, and 10 mM 0-glycerol phosphate on 22-mm Thermanox coverslips (U.S.A. Scientific, Ocala, FL) which were precleaned in 70% ethanol for 24 h [3] . Media were changed every 2 days throughout the culture period. Portions of cultures were treated with either 10' M dexamethasone (Sigma Chemical Co., St. Louis, MO) or 10-8 M 1,25(OH)2D3 (gift of Milan Uskokovic, Hoffman-LaRoche, Nutley, NJ) as indicated in the results. Groups of a = 3 were examined in each experiment.
In situ hybridization. Cells were rinsed twice in Hanks' balanced salt solution, fixed in 4% paraformaldehyde in PBS for 15 min at 25°C, rinsed, and stored in 70% ethanol at 4°C for at least 24 h. The probes used for hybridization were rat H4 histone [11] , rat osteocalcin [12] , rat osteopontin [13] , and type I collagen [14] . They were prepared by nick translation, labeled with [35S]dCTP, and passed through a G50 Sephadex spin column. The specific activity was 1-3 X 10" cprrilag. A sample of each prohe was then sized by electrophoresis on a denatured agarose minigel.
In preparation for hyhridization, the coverslips were rehydrated for 10 min in PBS, 5 mM MgC12 and either stored in 50% formamide, 2x SSC (0.3 M sodium citrate, 3.0 M sodium chloride, pH 7.25) awaiting hybridization or were RNase treated as a negative control. For the RNase controls, RNase A (100 ag/m1 in 2X SSC) was boiled for 10 min prior to use. After placing a 25-al drop of RNase A on a parafilmcovered glass plate, the coverslip was placed face down on the drop and the plate was covered with parafilm and incubated 1 h at 37°C. The coverslips were washed five times in 2X SSC and stored in 50% formamide, 2x SSC until hybridization.
Hybridization was carried out in 5 M dithiothreitol, 50% dextran sulfate, 2% bovine serum albumin, 20X SSC, and 1.0 M sodium phosphate, pH 6.0. An equal volume of hybridization mix was added to the denatured probe, avoiding air huhbles. Working quickly, a 20-al aliquot of hyhridization mix/prohe per coverslip was pipetted on a prewarmed (40-50°C) parafilm-covered glass plate. A coverslip was placed face down on the drop. The plate was covered with parafilm and incubated at 42°C for H4 histone, osteocalcin, and type I collagen and 50°C for osteopontin for 3 h. The coverslips were washed for 30 mM in 2X SSC, 50% formamide at their respective hybridization temperatures. The second and third washes were 15 min in 1X SSC at room temperature on a shaker. Coverslips were dehydrated for 2 min each in 70, 95, and 100% ethanol. They were then dried, mounted face up on a 3 X 1 microscope slide, and cured overnight.
Autoradiography for 'S-labeled cells. Following hybridization, coyerslips were prepared for autoradiography by melting 10 ml Ilford K5 emulsion at 42°C for 20 min, followed by addition of 1 vol of 0.6 M ammonium acetate. The coverslips were dipped and dried upright for 2 h at room temperature without a safelight. Slides were placed in a light-tight slide box with drierite and exposed for 2-3 weeks at 4°C. The slides were developed in 50% Kodak 019 for 5 min at 15°C, fixed, washed, and dried. Preparations were then stained in 0.5% toluidine blue, washed in 50 mM MgCl2 and distilled water, and dried.
Transmission electron microscopy (TEM). Coverslips with cultured rat osteoblasts were fixed (at indicated times throughout the results) in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer, washed, postfixed in 1% osmium tetroxide, rinsed, dehydrated, and embedded in Poly /Bed 812. Sections were cut, stained in uranyl acetate and lead citrate, and examined in a Philips 400 transmission electron microscope.
Scanning electron microscopy (SEM). Coverslips with cultured rat osteoblasts were fixed with 1% glutaraldehyde in 0.1 M sodium cacodylate buffer, rinsed, postfixed in 1% osmium tetroxide, dehydrated, critical point dried, and coated with gold palladium in a Technics Hummer Sputter Coater (Anatech, Alexandria, VA). Preparations were examined in an ETEC Autoscan scantling electron microscope.
Biochemical assays. Media (48-h changes) were assayed for secreted osteocalcin by a radioimmunoassay using anti-rat osteocalcin goat antisera and purified rat osteocalcin protein for standards and tracer as previously described 115]. Values are mean ± SD from n = 3 culture wells and presented as ng/ml, since cell layers on Thermanox coverslips were used for the in situ hybridization analyses.
RESULTS

Windows of Responsiveness to 1,25(OH) 2D3
We initially examined the effect of 1,25(OH) 2 D3 on cellular differentiation with addition of the hormone to the cultures at several developmental stages. Figure 1A schematically illustrates the experimental design. We utilized measurements of secreted osteocalcin in media, a marker of mature osteoblasts [4, 5] , to quantitate the extent of mineralized nodule formation. Since vitamin D regulates osteocalcin transcription only in postproliferative cultures with ongoing basal expression [16] , the effectiveness of vitamin D in upregulating osteocalcin synthesis also provides an index of cells expressing the mature phenotype influenced by 1,25(OH) ,D, Synthesis of osteocalcin in control cultures, which is induced postproliferatively with the onset of extracellular matrix mineralization on Day 14, peaks to maximal levels by Day 28 (Fig. 1B) . It is then downregulated in heavily mineralized cultures. If 10" M 1,25(OH) 2 D3 is added to the cultures during the proliferative period, an absence of osteocalcin expression is observed (Fig. 1B) . Cells did reach confluency, but extensive multilayering did not occur and thus no mineralized nodules were formed (compared Figs. 2B and 2D). This block in differentiation is maintained even when 1,25(OH) 2 D3 is withdrawn from media after the proliferation period. Additionally, when hormone is added to postproliferative cultures on Day 12, nodules that initially formed did not increase in size compared to control cultures. Induction of osteocalcin synthesis occurs ( ii.
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The effectiveness of 1,25(OH) 2 D3 in blocking differentiation when added to the cultures prior to nodule formation is further supported by addition on Day 8 (monolayer confluency), followed by removal on Day 12 (Fig.  1C) . Only a few nodules (and of smaller size) developed after Day 12 as reflected by the low level of osteocalcin synthesis. However, addition of hormone on Day 12 after nodules formed, for only 48 h, had a marginal effect in further maturation and mineralization of the nodule. This is indicated by the decreased osteocalcin level on Day 28 in the vitamin D-treated group which is 71% of control (Fig. 1C) .
Morphological Features of the Osteoblasts in Response to
Vitamin D When the cultures were examined morphologically (by light and electron microscopy), distinct changes in cell shape were observed after vitamin D was added, but selectively only in the nodule associated cells. croscopy (Fig. 4) of the osteoblast cultures. SEM confirmed the light level observations that only cells associated with, and in close proximity to, the nodule underwent a distinct cell shape change (Fig. 4B) . This effect on cell shape was observed within 48 h of hormone addition and remained even when hormone was removed from the culture media and the cells received it from feedings with control media (Fig. 3D) .
A nodule was cross-sectioned and examined by transmission electron microscopy ( Fig. 5A ) to determine the extent of ultrastructural changes throughout the multilayered cellular region. Figure 5 (B, C) indicates that only the surface cells were most markedly affected. Plump cuboidal osteoblasts were observed on the surface of the nodule in control cultures. In contrast, the surface cells of the 1,25(OH) 2 D3 treated cultures were elongated, flattened, and in closer proximity to each other. In both control and vitamin D-treated cells there were abundant rough endoplasmic reticulum studded with ribosomes, well-developed Golgi, numerous and elongated mitochondria, and the large, centrally located nucleus contained finely dispersed chromatin, all characteristic of a healthy osteoblast. Beneath the surface layer, abundant mineralized collagenous matrix surrounds each osteoblast. The cells at the bottom of the nodule on the plastic surface of both cultures were extremely flattened and elongated.
Visualization of Growth-and Differentiation-Related Gene Expression by in Situ Hybridization
It is necessary to fully comprehend: (1) the relationships of cell growth and expression of vitamin D-regulated bone phenotype genes (e.g., collagen, osteopontin, osteocalcin) as a function of the developmental sequence of osteoblast differentiation and (2) the observed selectivity in morphological changes. An analysis of gene expression at the single cell level was, therefore, carried out. 12B ). These patterns were independent of hormone effects.
Expression of osteocalcin and osteopontin, markers of the mature osteoblast phenotype, were previously reported to be localized to bone nodule-associated cells [3, 19] . When cultures with developing nodules are vitamin D-treated, a 6-to 10-fold increase in mRNA levels occurs for both genes. We observed enhanced expression of these vitamin D-regulated genes only in the noduleassociated cells as illustrated by osteocalcin in Fig. 7 . In situ hybridization at the single cell level revealed a positive reaction specifically in those cells which had an elongated morphology in response to 1,25(OH) ,D,. Internodular monolayer cuboidal cells were devoid of detectable osteocalcin (Fig. 7) or osteopontin (not shown) mRNA.
Windows of Cellular Responsiveness to Dexamethasone
It has been previously demonstrated that dexamethasone induces the formation of bone nodules in fetal rat calvarial-derived osteoblasts in a dose-dependent manner [8, 9] . This effect occurs maximally when hormone is added to osteoblasts during the proliferation period or at monolayer confluency [9] which is the basis for our experimental design (Fig. 8A) . As shown in Fig. 8B , osteocalcin levels, which reflect the extent of mineralized nodule formation, are elevated from 6-to 10-fold when dexamethasone is added to cultures from Day 2 after plating. The developmental time course is accelerated in these dexamethasone-treated cultures with osteocalcin synthesis induced to high levels earlier than in control cultures. When dexamethasone treatment was initiated on Day 7 at monolayer confluency, only a 2-to 3-fold increase in number of nodules and osteocalcin synthesis is observed. If dexamethasone is added to cultures on Day 13, following initiation of nodule formation in control cultures, a negligible effect on osteocalcin synthesis is observed with no change in the extent of -. -
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. mineralized nodule formation. Thus, the critical period of osteoblast responsiveness for dexamethasone to promote differentiation is prior to monolayer confluency. Furthermore, the effect of dexamethasone during proliferation in promoting nodule formation is sustained even upon removal of dexamethasone after two feedings (Fig. SC) .
Morphological Features of Dexamethasone-Exposed Cultures
By light microscopy (Figs. 9A and 9B) and confirmed by scanning electron microscopy ( Figs. 9C and 9D) , the nodules formed under the influence of dexamethasone are clearly larger, more heavily mineralized, and much Cross sections of the nodule areas (not shown) revealed a similar organization of cells and collagen layers throughout the nodules as found in controls, with the exception that nodule associated cells in the dexamethasone-treated cultures appeared much smaller in size. This observation is dramatically illustrated in Fig. 10 comparing nodule-associated cells at the same magnification from en face sections. The size differences between control (Fig. 10A) and dexamethasone-treated  cultures (Figs. 108-10D ) occurred throughout the cell layers. Cells in the dexamethasone-treated cultures were on the average 13-smaller than control cells. In both control and dexamethasone-treated cultures, typical features of an osteoblast were observed including a large centrally located nucleus and in the cytoplasm, abundant rough endoplasmic reticulum, mitochondria, and Golgi. Also observed in the nodules of dexamethasonetreated cultures were a number of dividing cells (Fig.  10D) . At this time, Day 18, histone mRNA levels are only 5% of the maximal level observed during the proliferation period [9] .
In Situ Hybridization Studies of DexarnethasoneTreated Cultures
The early effects of glucocorticoid on osteoblast growth were examined during the proliferation period by analysis of the level of histone gene expression. fluency, becoming the internodular region (Fig. 11F) . The regions showing more closely packed cells (Fig.  11E) are those areas which appear as nodules in the older cultures. Collagen expression was also more intense in the region of proliferating cells (see Figs. 6E and 6F) in dexamethasone-treated cultures. Thus, the observed two distinct regions of proliferative activity suggest that these proliferating osteoblasts exhibit differential responses to dexamethasone, a phenomena which was not observed in vitamin D-treated proliferating cells.
Expression of the genes reflecting the mature osteoblast phenotype, osteopontin and osteocalcin, were examined at two stages-the developing nodule on Day 8 and the mature nodule, after Day 18 (Fig. 12) . Osteopontin is detected in Day 3 proliferating cells (Fig. 12C ), but at confluency (Day 8), osteopontin expression was evident only in regions of closely packed cells that appeared to be areas of early nodule formation (Fig. 12D) . This pattern of expression reflected and clarified the analysis of gene expression represented in total cellular RNA from the cultures at different stages 19]. Osteopontin expression is significantly elevated, nearly 20-fold in early cultures exposed to dexamethasone, while osteocalcin expression is absent from proliferating cells and cannot be induced by dexamethasone. Cells expressing osteocalcin were found in more developed nodules. When these nodules have developed in the dexamethasone-treated cultures, the enhanced expression of osteocalcin is apparent (Fig. 12B) . Another difference between dexamethasone-modified osteopontin and osteocalcin expression was the detection of osteopontin mRNA in internodular cells (Fig. 12F ) of dexamethasone-treated cultures compared to controls (Fig. 12E) . This was not observed for osteocalcin.
DISCUSSION
Numerous reports have documented effects of the steroid hormones, glucocorticoid, and vitamin D in regulating bone activity and modulating expression of genes [reviewed in 10]. However, the relationship of the modifications in gene expression by these hormones to growth and maturation of the osteoblast has only recently been described [6, 7, 9, 20] . Osteoblasts cultured from cells harvested from a late digest of fetal rat calvaria appear initially to be a morphologically uniform population of cells that proliferate. This is reflected by the finding that 50% of the cells show positive expression for the histone gene which is coupled to DNA synthesis. In primary cultures, areas begin to multilayer and the extracellular matrix produced by these multilayered cells is competent to mineralize. The bone nodules produced in primary cultures, after extracellular matrix mineralization, contribute to a heterogenous population of cells defined by the stage of differentiation in relation to tissue formation. These include the internodular osteoblasts, the cells completely surrounded by a mineralized matrix within the nodule that appear to have features of an osteocyte-like cell with cellular extensions (Fig. 5) , and the surface osteoblasts actively synthesizing and secreting matrix. These features of cell and tissue organization are similar to bone in vivo [21] . By analysis of the cultures at the single cell level using in situ hybridization, our observations show (1) differences in the level of gene expression as a function of cellular location; (2) a selectivity of hormone effects on gene expression dependent upon the stage of osteoblast differentiation (in vitro). The present studies have also revealed morphologic changes ;.
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nr-" -:;.., which accompany hormone responsiveness in mature osteoblasts. Additionally, our studies support other findings that the osteoblast-like cell which is derived from mineralized areas of fetal calvaria and, at one point, expressed features of a mature osteoblast phenotype, can be redirected as a proliferating cell in its developmental programming by glucocorticoid [8, 9, 22] and vitamin D [6, 7] . The present in situ hybridization studies establish that these responses occur by hormone-targeted effects apparently on a subpopulation of cells that are not distinguishable by morphology during the proliferation period.
Selective Effects of 1,25(OH) 2D3 on Osteoblast Growth and Differentiation
The inhibition of bone nodule formation by addition of 1,25(OH) 2 D3 to proliferating cells cannot be accounted for by a complete inhibition of proliferation since the cells express the histone gene and come to monolayer confluency. However, 1,25(OH) 2 Da could selectively block proliferation of a subset of cells that would generate the multilayered nodule. In situ hybridization reveals that all proliferating cells express collagen and respond to vitamin D. The decrease in collagen gene expression after vitamin D treatment may affect further development of cellular multilayering by an absence of signaling events between osteoblasts and matrix that would normally contribute to formation and growth of the nodule. Furthermore, the extracellular matrix may permit an accumulation of factors that potentiates additional proliferation of nodule-forming cells. This interpretation is also supported by the observation of inhibited growth and development of the nodule when 1,25(OH) 2D3 is added at the onset of nodule formation. Here, collagen expression and accumulation are also decreased.
In developing and in mature mineralized nodules, an upregulation of osteocalcin and osteopontin in the nodule associated cells is evident, thus suggesting that vitamin D has promoted differentiation. It is striking that no expression of these parameters can be detected in internodular cells. This pattern of expression is similar to control cultures [3] . These observations at the single cell level thus support the concept that for osteocalcin and osteopontin, vitamin D modulates expression of genes where basal transcription is ongoing. In this in vitro system, it appears that vitamin D is not capable of inducing differentiation of a proliferating osteoblast or further differentiation of the internodular cell in established cultures. Rather, the hormone promotes expression of genes reflecting a more differentiated stage of maturation in the nodule-associated cells.
The significance of the marked changes in cell morphology in the nodule-associated cells by vitamin D is intriguing. Cytoskeletal effects (changes in microfilament organization) by vitamin D in human osteoblasts, rat calvarial-derived, and rat osteosarcoma cells have also been previously reported [23, 24] . The hormone effect was found to be dose-dependent between 10-12 and 10-9 M and was inhibited by cycloheximide. In the present studies, marked changes in cell morphology occurred in the surface layer cells associated with the mature bone nodule. In vivo, after active bone formation, a flattened cell lines the quiescent bone surface [25] . In vitro, the morphological changes we observe may reflect the ability of 1,25(OH) 2 D3 to promote differentiation of an active osteoblast to a flattened lining cell. Alternatively, since 1,25(OH) 2D3 promotes bone resorption, the change in morphology may facilitate the activity of surface osteoblasts to function during bone turnover. There is a clear transition of the surface cell from a plump cuboidal osteoblast secreting collagen matrix to an elongated flattened cell that expresses high levels of the noncollagenous proteins, osteocalcin and osteopontin. The selective upregulation of osteocalcin and osteopontin in mature osteoblasts may relate to the physiological functions of these proteins in vivo. Osteocalcin [26, 27] and osteopontin [28] [29] [30] have both been implicated in mediating osteoclast activity. The bone resorting cell, the osteoclast, is stimulated by hormones (PTH and vitamin D) indirectly via the osteoblast [31] . Osteoclast formation and activation occurs on the surface of bone and the dramatic change in cell morphology may reflect the necessity for retraction of surface osteoblasts during active resorption to allow for osteoclast adhesion. Recent studies have indicated that the mature nodule-associated cells are also selectively responsive to parathyroid hormone [32] , further supporting the concept of osteoblasts in the mineralized matrix functioning differently than the monolayer internodular osteoblasts.
Selective Effects of Glucocorticoids on Osteoblast Growth and Differentiation
The differentiation-promoting properties of dexamethasone were clearly most potent when proliferating cells were exposed to the hormone. Both growth-inhibited and growth-stimulated cell populations were observed during the proliferation period in glucocorticoidtreated cultures. The proliferating stage of the osteoblasts and perhaps the cell cycle period may be a prime contributing factor in eliciting the selective growth response of dexamethasone. Nodule-associated cells in the glucocorticoid-treated cultures have the ability to proliferate for a longer period of time in culture, reflected by the increased number of mitotic cells (Fig.  10) , resulting in the larger-size nodules. These observations of H4 gene expression which is coupled to DNA synthesis, at the single cell level, are consistent. with and clarify the previously observed biphasic effects of dexamethasone on H4 mRNA levels measured in total cellular RNA preparations from cultured osteoblasts [9] . By the matrix maturation period (Day [13] [14] of the control cultures, treatment with dexamethasone did not stimulate the committed nonproliferating cells throughout the culture to increase the size of the nodule or accelerate the mineralization process further.
Although the postproliferative cells were refractory to growth stimulation, they were responsive to glucocorticoid, as indicated by enhanced mRNA levels for osteocalcin and osteopontin in the cultures. Osteocalcin was upregulated only in nodule-associated cells which exhibited basal expression. It should be noted that this upregulation of osteocalcin in response to dexamethasone may be secondary to the differentiating promoting properties of glucocorticoids on these fetal rat-derived osteoblasts. However, in human osteoblast-like cells derived from adult bone, glucocorticoids decrease osteocalcin mRNA and protein levels [33, 34] . Thus, there may be a species difference with respect to osteocalcin gene regulation by glucocorticoids [35] [36] [37] in addition to contributions from the stage of osteoblast maturation [9, 16] . Osteopontin, on the other hand, was upregulated in cells irrespective of the stage of differentiation or tissue organization. The early and enhanced expression of osteopontin in the dexamethasone-treated cultures in relation to the developing nodules may be related to properties of the protein. Its R-G-D sequence may promote the cell-cell and cell-matrix interactions involved in nodule formation [13] . Our observation and those of others that glucocorticoid produces many more nodules suggests that the hormone is stimulating a specifically targeted cell to proliferate and produce the nodule [8, 9, 22] . Alternatively, glucocorticoids could suppress proliferation of a cell that will not multilayer. The fact that some cells become flattened and spread may contribute to the more focal nature of the nodules in dexamethasonetreated cultures. The effects of dexamethasone on the size of the osteoblast, which is approximately one-third smaller than in the control cultures, may also contribute to the focal nature of the nodule. The smaller size of the more differentiated dexamethasone-treated cell may be a reflection of the transition of the plump cuboidal osteoblast to a more osteocytic-like cell, since nodules in the glucocorticoid-treated cultures mineralize earlier and to a greater extent than nodules in control cultures. A few osteocytic-like extensions were observed, but generally the cell was as rich in endoplasmic reticulum and golgi as in the control osteoblast, suggesting that the cell was still actively secreting protein.
In conclusion, our in situ hybridization studies clearly demonstrate selective influences of two steroid hormones on subsets of cells that result from osteoblast differentiation in cultures of calvarial derived cells. In vitamin D-treated cultures, a uniform response was observed in cells throughout the proliferation period as indicated by the decrease in collagen mRNA. In contrast, dexamethasone-treated proliferating cells exhibited regions of cells that became extremely spread and flattened and regions of proliferating smaller cuboidal shaped osteoblasts that were more concentrated, creating areas of increased density. These differences suggest that either different types of cells occur in the fetalderived population or that during the proliferative phase, these hormones may have selective effects in altering the phenotype, perhaps dependent upon the stage of the cell cycle [38] , when first exposed to high levels of hormones. The hormonal effects are clearly osteoblast stage-dependent, as indicated by the selective upregulation of osteopontin and osteocalcin. Further complexity of hormonal regulation in individual cells is evident from the extent of upregulation of the osteocalcin and osteopontin genes [6, 9, 10, 39] . Variability both in basal expression and hormone-mediated upregulation was noted particularly in the cells at the periphery of the nodule by these in situ hybridization studies. However, such complexity may provide a basis for the requisite biological diversity of osteoblast activity in vivo necessary for supporting mineral homeostasis, bone turnover, and tissue integrity.
